MCP to host talks by
four emerging investigators

Published March 01 2019

The editorial leadership team of the journal Molecular & Cellular Proteomics has chosen four early-career investigators to present their current research during a symposium on Monday, April 8, at the American Society for Biochemistry and Molecular Biology annual meeting.

Al Burlingame, MCP editor and chair of the session, said of the four, “They represent the breadth of biomedical and basic biological research challenges that are being tackled currently by mass spectrometry-based proteomics. They also represent research programs at the forefront of proteomics that develop new methodologies to address and solve particular unmet needs in discovery of protein-level molecular assembly and function in both Europe and the United States. Two were trained in the US and two in Europe.”

The MCP early-career researchers

Jennifer Abelin Jennifer Abelin, a group leader at the biotech company Neon Therapeutics, is supporting research of how genetic mutations, a hallmark of cancer, can result in specific immune targets called neoantigens, and how neoantigens can be used to develop cancer immunotherapies.
Jana Zecha Jana Zecha, a graduate student in Bernhard Küster’s lab at the Technical University of Munich, has developed a methodology for studying turnover of proteins in cells at a proteome-wide scale.
Fan Liu Fan Liu, a new faculty member at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin, has studied the architecture of protein super-complexes in heart mitochondria using distance constraints obtained from chemical cross-linking and mass spectrometry.
Samuel Myers Samuel Myers, a research scientist at the Broad Institute, has developed a powerful alternative to ChIP that employs a new CRISPR-localized proximity labeling method to capture and identify protein complexes at specific genetic loci.